PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.\', \'Collège Doctoral, Sorbonne Université, Paris, France.\', \'Santé Publique France, French National Public Health Agency, Saint-Maurice, France.\', \'Haute Autorité de Santé, Saint-Denis la Plaine, France.\', \'Institut Pierre Louis d\'Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.\', \'Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France.\', \'PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2021.26.26.2100533
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34212840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all